3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
27
Lymphoid
19
Genitourinary
8
CNS
8
Gastrointestinal
6
Other
3
Thoracic
1
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Gynecologic
1
Classical hematology
1
Conditions
Multiple Myeloma
1663
Neoplasms, Plasma Cell
415
Lymphoma, Non-Hodgkin
311
Lymphoma
283
Hodgkin Disease
281
Leukemia, Lymphocytic, Chronic, B-Cell
274
Precursor Cell Lymphoblastic Leukemia-Lymphoma
246
Leukemia, Myeloid, Acute
223
Leukemia
220
Lymphoma, Mantle-Cell
196
Lymphoma, Large B-Cell, Diffuse
196
Lymphoma, Follicular
196
Myelodysplastic Syndromes
194
Recurrence
185
Lymphoma, B-Cell, Marginal Zone
178
Burkitt Lymphoma
172
Lymphoma, Large-Cell, Immunoblastic
161
Myeloproliferative Disorders
146
Leukemia, Myeloid, Chronic-Phase
134
Leukemia, Myeloid, Accelerated Phase
122
Primary Myelofibrosis
121
Immunoglobulin Light-chain Amyloidosis
120
Waldenstrom Macroglobulinemia
119
Lymphoma, T-Cell, Cutaneous
119
Blast Crisis
114
Leukemia, Myelomonocytic, Chronic
105
Sezary Syndrome
100
Mycosis Fungoides
100
Neoplasms
97
Leukemia, Hairy Cell
95
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cognitive Dysfunction
×
Plasma cell
×
Clear all
NCT02767388
2023-09-29
Chemobrain
University of Nebraska
Completed
45 enrolled
10 charts